Dr. Gregory Bunt (USA) M.D.
Dr. Gregory Bunt graduated medical school in 1983 from NYU School of Medicine, and completed his residency in Psychiatry at the Albert Einstein College of Medicine in 1987.
He was among the first to complete the Fellowship in Addiction Psychiatry at NYU School of Medicine (1989), and has since been on the NYU Medical School Faculty in the Division of Alcoholism and Drug Abuse, currently as an Assistant Clinical Professor of Psychiatry. He is a diplomat of the American Board of Psychiatry and Neurology with Special Added Qualifications in Addiction Psychiatry.
Dr. Bunt is the Immediate Past President of the New York Society of Addiction Medicine and currently the President of the International Society of Addiction Medicine. He has been the Medical Director for Daytop Village and Daytop International for 25 years. He has authored over a dozen publications, and speaks nationally and internationally about addiction medicine and therapeutic communities.
Dr. Kathleen T. Brady (USA) M.D., Ph.D.
Distinguished University Professor, Vice President for Research, Medical University of South Carolina
Dr. Brady is an experienced clinical and translational researcher and has been conducting scientific investigations and clinical work in the field of addictions and psychiatric disorders for over 30 years. Her research focuses on pharmacotherapy of substance use disorders, comorbidity of psychiatric disorders and addictions (e.g., posttraumatic stress disorder and bipolar disorder), gender differences and women’s issues in addictions, and the neurobiologic connections between stress and addictions. She has received numerous federal research grants and has published over 300 peer-reviewed journal articles and co-edited 10 books. She is the principal Investigator of MUSC’s Clinical and Translational Science Award (CTSA), Principal Investigator of the Southern Consortium Node of the NIDA-funded Clinical Trials Network and Director of MUSC’s Women’s Research Center. Her dedication to furthering research careers has attracted a number of junior investigators and clinicians. She has mentored over 25 individual NIH-funded faculty development awards (K-awards) and is presently involved in three institutional faculty development programs (CTSA KL2; BIRCWH, NIDA K-12). She has been the Co-Director of MUSC’s NIH- funded post-doctoral fellowship program focused on translational research training in addictions for 15 years.
Dr. Riaz Khan (Switzerland)
Dr. Hannu Alho (Finland) MD, PhD, Specialist in Addiction Medicine
Professor Hannu Alho (05.12.1951), Finnish Citizen
Professor of Addiction Medicine, Institute of Clinical Medicine, University of Helsinki, Finland
and Research Professor, Department of Mental Health and Substance Abuse, National Institute of Health and Welfare, Helsinki
and Chief Physician, Department of Alcohol Abuse, Helsinki University Hospital
Main interests: clinical research on pharmacological treatment of alcoholism, prevention of alcohol-related health problems, treatment of pathological gambling and treatment opiate addictions. Professor Alho’s research team was one of the first to demonstrate that targeted (as needed) opiate antagonist treatment naltrexone is effective in reducing alcohol consumption and since has been active in the development and testing of related treatments.
Publications: 219 original articles (208 in Web of Science), 5440 citations, 13 papers have > 100 citations, h-index 39, several publications and books on Teaching and Addiction Medicine in Finnish.
Current Position of Trusts:
ISAM Board member since 2004
Former President of International Society for Addiction Medicine (ISAM).
Past Chairman of the Finnish Society of Addiction Medicine
Past Chairman of the Finnish Society of Alcohol and Drug Research
Editorial Board, Substance Abuse
Finnish Medical Journal Duodecim
Chief Editor Gambling Disorders, Alcohol Disorders, Drug Abuse (in Finnish)
Hannu Alho, professor
National Institute of Health and Welfare
POB 30, 00271 Helsinki, Finland
tel +358-29 524 8123, mob. +358-40 5823339, fax +358-29 524 8133, firstname.lastname@example.org
Dr. Sung-Gon Kim (Korea) MD, PhD
Sung-Gon Kim MD, PhD has taught alcoholism at Pusan National University (PNU) and helped alcoholic patients at PNU Hospitals since 1994. After working at Addiction Treatment Center at University of Pennsylvania as a visiting scholar for 1 year (1993), Professor Kim has focused on alcoholism research as a pioneer in Korea for the last 25 years.
He has served his community as a director at Pusan Alcohol Counseling Center for the last 16 years. He was the President of Korean Academy of Addiction Psychiatry (KAAP) between 2010 and 2012. He is a member of the editorial board for Journal of KAAP and ACER.
Dr. Jens Reimer (Germany)
Professor Jens Reimer, MD, MBA Centre for Interdisciplinary Addiction Research University Medical Centre Hamburg-Eppendorf (UKE), Germany Centre for Psychosocial Medicine, Health North, Bremen, Germany Fon: +49 40 74105 7900; Email: email@example.com
Positions and selected Functions:
Dr. Alex Baldacchino (UK) MD, MRCPsych, FRCPsych, FRCPE, FISAM, MPhil, PhD
My main professional interest lies in improving the lives of individuals with a history of substance misuse problems. I hold a joint clinical academic position with the University of St Andrews as Professor of Medicine, Psychiatry and Addictions together with NHS Scotland as Senior Consultant and Clinical Director in Addiction Medicine with NHS Fife.
My research portfolios have a common thread of understanding the comorbid conditions (physical and psychological) arising as a result of chronic abuse of pharmacological agents of dependence potential especially opioids and alcohol. I am interested in utilising informatics and other digital health science systems, clinical outcome data, neuropsychological and neuroimaging processes amongst many other possibilities in order to identify and minimise risks present in this patient population
I graduated as a doctor in Malta in 1987 gaining my MD in the process. I eventually decided to study psychiatry as my clinical specialisation following a period of internal medicine jobs. I therefore joined the basic and higher psychiatric schemes in the UK (Cambridge, Edinburgh, Fife and London) in order to fulfil my requirements as a general psychiatrist and as a specialist in addiction medicine. I was awarded my Membership and Fellowship with the Royal College of Psychiatrists (United Kingdom) (MRCPsych in 1994 and FRCPsych in 2007) and Fellowship with the Royal College of Physicians (Edinburgh) (FRCPE) in 2016. Always interested in research and teaching in addiction medicine I pursued an academic career alongside my basic medical and higher psychiatric training. I joined as a lecturer and senior lecturer with St George’s Hospital Medical School in London and then with Ninewells Hospital Medical School in Dundee. I was awarded my MPhil in Psychiatry from the University of Edinburgh in 1996 and a PhD in Medicine from the University of Dundee in 2012.
I am an Executive Board Member and Co-Chair for the Training and Education Committee of the International Society of Addiction Medicine (ISAM). In 2016 I have been awarded the ISAM Fellowship (FISAM). I am also founding member for the European Network for Training, Education and Research (ENTER)-Mental Health and the Centre for Addiction Research and Educations Scotland (CARES). Other positions include Associate Director for the Social Dimensions of Health Institute (SDHI), NHS Fife Research and Development (R&D) Director and President for ISAMDundee2015 World Congress.
Last but certainly not least I am honoured to spend time with patients who need the best of clinical care and compassion and where, I hope, my intervention makes a difference in their quality of life.
Dr. Nady el-Guebaly MD, FRCPC, DPH, DPsych, DABAM, CISAM, DFASAM, DFAAAP, EFACP, DFCPA
Dr. el-Guebaly’s introduction to mental health and addiction medicine dates back to 1969 during initial psychiatric training in the United Kingdom, followed by training in Canada and the United States
Addiction related work includes being the current Professor and Head of Division of Addiction, Department of Psychiatry at the University of Calgary, and the founding past Medical Director of the Calgary Health Region Addiction Centre and Program. Dr. el-Guebaly was the Founding Past President of the International Society of Addiction Medicine, its Executive Medical Director for another 6 years, and currently Chief Examiner of the International Certification Examination and Senior Editor of the recent Textbook of Addiction Treatment: International Perspectives (Springer 2015).
Dr. el-Guebaly completed three 3-year terms as Board Chair of the Alberta Gaming Research Institute, and is now the Alberta Gambling Research Institute’s current Research Director as well as Editor in Chief of the Canadian Journal of Addiction for the last 4 years. These interests have resulted in 260 peer-reviewed papers, 80 chapters, 568 presentations, and 60 past and current grants totaling $7 million.
He is a member, of Alberta’s Responsible Gambling Advisory Committee, the Royal College Addiction Medicine Specialty Committee, the Provincial Addiction Curricula and Experiential Skills Training for Alberta Health Services, and the CSAM Conference committee.
Dr. Marc Galanter (USA)
Marc Galanter, M.D. is a Professor of Psychiatry at NYU. He has served as a Clinical Associate at the U.S. National Institute of Mental Health; as President of the Association for Medical Education and Research in Substance Abuse, the American Academy of Addiction Psychiatry, and the American Society of Addiction Medicine; and as Chief Editor of the International Society of Addiction Medicine.
He founded the Division of Alcoholism and Drug Abuse at NYU and the journal “Substance Abuse;” is co-editor of the American Psychiatric Association’s “Textbook of Substance Abuse Treatment,” and has published over 200 peer-reviewed articles, addressing pharmacologic and psychosocial treatment for addiction, and the psychology of Twelve-Step recovery.
He has received the Gold Achievement Award for innovation in treatment and the Seymour Vestermark Award for psychiatric education from the American Psychiatric Association; the Smithers Distinguished Scientist Award from ASAM; and New York State’s Award for Psychiatric Research.
Mrs. Marilyn Dorozio
Marilyn specializes in event management and organization. From the initial proposal to project conclusion, clients worldwide know that their event will be managed with the same project management process Marilyn uses in every conference she takes on.
Sometimes referred to as the “organizing guru extraordinaire” Marilyn can also wrestle a client’s office from chaos to clarity by creating administrative systems for their paperwork and data, especially the financial, which typically is the stopping point for many small business owners.
Fluent in English, Spanish and a working knowledge of French, Marilyn is well-versed in differing cultural expectations and settings and offers the same C-Suite experience to each and every client.
Past Board Members no Longer on Board:
|Wayne Moran||Hong Kong|
|Joao da Silva||Brazil|
|Maria Cristina Delgado Pich||Argentina|
|Tarek Gawad, Past President||Egypt|